Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Child survival strongly linked to maternal survival in Uganda

Child mortality goals are unlikely to be met in societies which fail to pay attention to the survival of HIV-positive mothers, according to findings from

Published
05 August 2003
By
Keith Alcorn
Talking about side-effects

Monitoring and communication about antiretroviral side-effects in low-resource settings.

Published
08 May 2003
From
HIV & AIDS treatment in practice
GSK cuts price of HIV drugs to poorest countries

Pharmaceutical giant, GlaxoSmithKline (GSK), has announced that it is halving the price of some of the drugs in its anti-HIV portfolio for 63 nations, including

Published
28 April 2003
By
Michael Carter
Combining ARVs with treatment for tuberculosis

Combining antiretroviral drugs (nevirapine / efavirenz / protease inhibitors) with tuberculosis drugs, including rifampicin.

Published
10 April 2003
From
HIV & AIDS treatment in practice
Nevirapine-based fixed-dose combination ARVs

This article describes the early use of nevirapine-based fixed dose antiretroviral combinations in low and middle-income settings.

Published
27 March 2003
From
HIV & AIDS treatment in practice
South African HIV treatment activists start civil disobedience programme

HIV treatment activists in South Africa are using the civil disobedience tactics employed by the governing ANC to bring down the apartheid regime to highlight

Published
25 March 2003
By
Michael Carter
AIDS dissident appointment `last straw` in battle of activists and South African Health Minister

The Treatment Action Campaign has called for the removal of South African Health Minister Manto Tshabalala-Msimang for inviting an infamous AIDS dissident, Robert Giraldo, to

Published
11 March 2003
By
Theo Smart
GSK acquire rights to develop new CCR5 antagonist

Today in London, GlaxoSmithKline (GSK) announced it has acquired exclusive worldwide rights to ONO-4128, a new cellular chemokine receptor (CCR5) antagonist discovered by Japan’s Ono

Published
17 January 2003
By
Robert Fieldhouse
Controversial Thai “treatment” loses key supporter

A Thai charity, the Salang Bunnag Foundation, which paid for the mass distribution of a product called V-1 Immunitor, is reported to have withdrawn its

Published
02 September 2002
By
Julian Meldrum
Trizivir approved in Europe

The three-in-one pill anti-HIV medication Trizivir has been approved for use in Europe, the European Medicines Agency announced yesterday. The drug is likely to be

Published
05 March 2001
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.